Home > Aisling Capital acquires BioRelix, Inc.
Transaction · Life Science

Aisling Capital acquires BioRelix, Inc.

Aisling Capital acquired BioRelix, Inc., a life science company in Connecticut, United States.

Deal at a glance

TargetBioRelix, Inc. Buyer Aisling Capital SectorLife Science LocationConnecticut, United States ValueNot disclosed

Target company

BioRelix, Inc.
Connecticut, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Private equity firm · 88 deals on record
88deals, all time
65in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

OmnioseSame sector and country · Nov 2026
Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026

Questions about this deal

Who acquired BioRelix, Inc.?Aisling Capital acquired BioRelix, Inc..

What type of deal was it?It was a transaction in the life science sector.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).